These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33264209)

  • 1. Educating Nurses on the Use of the Clinical Opiate Withdrawal Scale to Improve Care of Adult Patients Undergoing Buprenorphine Induction.
    J Addict Nurs; 2020; 31(4):E38-E39. PubMed ID: 33264209
    [No Abstract]   [Full Text] [Related]  

  • 2. Educating Nurses on the Use of the Clinical Opiate Withdrawal Scale to Improve Care of Adult Patients Undergoing Buprenorphine Induction.
    Uga CO; Noe SR; Lynch SA; Summers LO
    J Addict Nurs; 2020; 31(4):229-235. PubMed ID: 33264194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-assisted treatment for opioid use disorder.
    Kaplan L
    Nurse Pract; 2019 Mar; 44(3):10-12. PubMed ID: 30585906
    [No Abstract]   [Full Text] [Related]  

  • 4. CE: Acute Pain Management for People with Opioid Use Disorder.
    Broglio K; Matzo M
    Am J Nurs; 2018 Oct; 118(10):30-38. PubMed ID: 30211703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public policy statement on buprenorphine for opiate dependence and withdrawal.
    J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969
    [No Abstract]   [Full Text] [Related]  

  • 6. Home Induction of Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy.
    Kelly JC; Raghuraman N; Stout MJ; Russell S; Perez M; Nazeer S; El Helou N; Zhang F; Carter E
    Obstet Gynecol; 2021 Oct; 138(4):655-659. PubMed ID: 34623078
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder.
    Schroeder JR; Phillips KA; Epstein DH; Jobes ML; Furnari MA; Kennedy AP; Heilig M; Preston KL
    Psychopharmacology (Berl); 2018 Oct; 235(10):2957-2966. PubMed ID: 30079432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
    Dunn KE; Tompkins DA; Bigelow GE; Strain EC
    JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-purposing anticoagulation clinics: expanding access to opioid agonist therapy in primary care settings.
    Lagisetty P; Heisler M; Bohnert A
    Addiction; 2017 Mar; 112(3):384-385. PubMed ID: 27550143
    [No Abstract]   [Full Text] [Related]  

  • 10. Buprenorphine-naloxone.
    Hu T; Nijmeh L; Pyle A
    CMAJ; 2018 Nov; 190(47):E1389. PubMed ID: 30478217
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.
    Cisewski DH; Santos C; Koyfman A; Long B
    Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.
    Webster L; Hjelmström P; Sumner M; Gunderson EW
    J Addict Dis; 2016; 35(4):325-338. PubMed ID: 27267785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.
    Ward HB; Barnett BS; Suzuki J
    Subst Abus; 2019; 40(2):140-145. PubMed ID: 30888254
    [No Abstract]   [Full Text] [Related]  

  • 15. Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal.
    Srivastava A; Kahan M; Njoroge I; Sommer LZ
    Can Fam Physician; 2019 May; 65(5):e214-e220. PubMed ID: 31088887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prescribing of buprenorphine by advanced practice addictions nurses.
    Strobbe S; Hobbins D
    J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving temporal efficiency of outpatient buprenorphine induction.
    Gunderson EW; Levin FR; Rombone MM; Vosburg SK; Kleber HD
    Am J Addict; 2011; 20(5):397-404. PubMed ID: 21838837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding ED Buprenorphine Initiation for Opioid Use Disorder: A Guide for Emergency Nurses.
    Strout TD; Baumann MR; Wendell LT
    J Emerg Nurs; 2021 Jan; 47(1):139-154. PubMed ID: 33390217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 20. Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment.
    Binswanger IA
    N Engl J Med; 2019 Mar; 380(13):1193-1195. PubMed ID: 30811904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.